U.S. Department of Health and Human Services

Special Diabetes Program: Funding Opportunities Archive

These funding opportunities are closed. They are supported in whole or in part by the Special Statutory Funding Program for Type 1 Diabetes Research. For information on the scientific accomplishments resulting from these opportunities, please see Reports and Planning.

View current research funding opportunities supported by the Special Diabetes Program.

1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017       

 

2017

Limited Competition: Follow-up on Subjects and Immunological Assessments in The Environmental Determinants of Diabetes in the Young Study (TEDDY) (UC4)
Posted Date: December 15, 2016
Open Date (Earliest Submission Date): February 15, 2017
Letter of Intent Due Date: February 15, 2017
Application Receipt Date: March 15, 2017 by 5:00PM local time of applicant organization


Competitive Collaborative Projects for Human Islet Biology (UC4)
Posted Date: December 14, 2016
Open Date (Earliest Submission Date): February 23, 2017
Letter of Intent Due Date: February 23, 2017
Application Receipt Date: March 23, 2017 by 5:00PM local time of applicant organization

Therapeutic Targeting of The Human Islet Environment (UC4)
Posted Date: December 14, 2016
Open Date (Earliest Submission Date): February 22, 2017
Letter of Intent Due Date: February 22, 2017
Application Receipt Date: March 22, 2017 by 5:00PM local time of applicant organization

Limited Competition: Data Coordinating Center for Type 1 Diabetes TrialNet (UC4)
Posted Date: December 5, 2016
Open Date (Earliest Submission Date): February 14, 2017
Letter of Intent Due Date: February 14, 2017
Application Receipt Date: March 14, 2017 by 5:00PM local time of applicant organization

Limited Competition: Continuation of the Preventing Early Renal Loss in Diabetes (PERL) Study (UC4)
Posted Date: December 1, 2016
Open Date (Earliest Submission Date): February 2, 2017
Letter of Intent Due Date: February 2, 2017
Application Receipt Date: March 2, 2017 by 5:00PM local time of applicant organization


2016 

Neurocognitive Effects of Glycemic Dysregulation in Type 1 Diabetes (DP3)
Posted Date: June 15, 2016
Open Date (Earliest Submission Date): October 14, 2016
Letter of Intent Due Date: October 14, 2016
Application Receipt Date: November 14, 2016 by 5:00PM local time of applicant organization


Limited Competition for the Continuation of The Collaborative Islet Transplantation Registry
(UC4)
Posted Date: June 14, 2016
Open Date (Earliest Submission Date): October 21, 2016
Letter of Intent Due Date: October 21, 2016
Application Receipt Date: November 21, 2016 by 5:00PM local time of applicant organization

Standardization of C-peptide and HbA1c Measurements Program (UC4)
Posted Date: May 23, 2016
Open Date (Earliest Submission Date): October 22, 2016
Letter of Intent Due Date: October 22, 2016
Application Receipt Date: November 22, 2016 by 5:00PM local time of applicant organization

Human Islet Distribution Coordinating Center
(UC4)
Posted Date: March 31, 2016
Open Date (Earliest Submission Date): October 22, 2016
Letter of Intent Due Date: October 22, 2016
Application Receipt Date: November 22, 2016 by 5:00PM local time of applicant organization

Study to Assess the Incidence of Type 1 Diabetes in Young Adults (U18)
Posted Date: December 18, 2015
Open Date (Earliest Submission Date): December 18, 2015
Letter of Intent Due Date: January 22, 2016
Application Receipt Date: February 23, 2016 by 5:00PM local time of applicant organization
 
Improving Diabetes Management in Children with Type 1 Diabetes (DP3)
Posted Date: December 8, 2015
Open Date (Earliest Submission Date): May 22, 2016
Letter of Intent Due Date: May 22, 2016
Application Receipt Date: June 22, 2016 by 5:00PM local time of applicant organization
 
Understanding Barriers and Facilitators to Type 1 Diabetes Management in Adults (DP3)
Posted Date: December 8, 2015
Open Date (Earliest Submission Date): May 22, 2016
Letter of Intent Due Date: May 22, 2016
Application Receipt Date: June 22, 2016 by 5:00PM local time of applicant organization
 
Improving Diabetes Management in Pre-teens, Adolescents and/or Young Adults with Type 1 Diabetes (DP3)
Posted Date: December 8, 2015
Open Date (Earliest Submission Date): May 22, 2016
Letter of Intent Due Date: May 22, 2016
Application Receipt Date: June 22, 2016 by 5:00PM local time of applicant organization
 
Development of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (R43/R44)
Posted Date: November 19, 2015
Open Date (Earliest Submission Date): May 28, 2016
Letter of Intent Due Date: May 28, 2016
Application Receipt Date: June 28, 2016 by 5:00PM local time of applicant organization
 
Human Pancreas Procurement and Analysis Program (HPPAP) (UC4)
Posted Date: October 29, 2015
Open Date (Earliest Submission Date): February 3, 2016
Letter of Intent Due Date: February 3, 2016
Application Receipt Date: March 3, 2016 by 5:00PM local time of applicant organization
 
Research Using Biosamples and Subjects from Type 1 Diabetes Clinical Studies--Complications (DP3)
Posted Date: October 8, 2015
Open Date (Earliest Submission Date): February 3, 2016
Letter of Intent Due Date: February 3, 2016
Application Receipt Date: March 3, 2016 by 5:00PM local time of applicant organization
 
Limited Competition: Understanding How Epigenetics and Infections Impact Autoimmunity and Diabetes in The Environmental Determinants of Diabetes in the Young Study (TEDDY) (UC4)
Posted Date: October 2, 2015
Open Date (Earliest Submission Date): February 3, 2016
Letter of Intent Due Date: February 3, 2016
Application Receipt Date: March 3, 2016 by 5:00PM local time of applicant organization
 
Impact of the Use of Glucose Monitoring and Control Technologies on Health Outcomes and Quality of Life in Older Adults with Type 1 Diabetes (DP3)
Posted Date: September 24, 2015
Open Date (Earliest Submission Date): February 3, 2016
Letter of Intent Due Date: February 3, 2016
Application Receipt Date: March 3, 2016 by 5:00PM local time of applicant organization
 
Clinical, Behavioral and Physiological Research Testing Current and Novel Closed Loop Systems (DP3)
Posted Date: September 18, 2015
Open Date (Earliest Submission Date): May 28, 2016
Letter of Intent Due Date: May 28, 2016
Application Receipt Date: June 28, 2016 by 5:00PM local time of applicant organization
 
Advanced Clinical Trials to Test Artificial Pancreas Device Systems in Type 1 Diabetes (UC4)
Posted Date: September 2, 2015
Open Date (Earliest Submission Date): February 9, 2016
Letter of Intent Due Date: February 9, 2016
Application Receipt Date: March 9, 2016 by 5:00PM local time of applicant organization
 
Type 1 Diabetes Pathfinder Award (DP2)
Posted Date: July 29, 2015
Open Date (Earliest Submission Date): January 17, 2016
Letter of Intent Due Date: January 17, 2016
Application Receipt Date: February 17, 2016 by 5:00PM local time of applicant organization
 
Mechanisms Underlying the Contribution of Type 1 Diabetes Risk-Associated Variants (DP3)
Posted Date: July 7, 2015
Open Date (Earliest Submission Date): January 17, 2016
Letter of Intent Due Date: January 17, 2016
Application Receipt Date: February 17, 2016 by 5:00PM local time of applicant organization

2015 

Understanding the Pathogenesis and Etiology of Type 1 Diabetes Using Biosamples and Subjects from Clinical Studies (DP3)
Posted Date: August 4, 2015
Open Date (Earliest Submission Date): October 12, 2015
Letter of Intent Due Date: October 12, 2015
Application Receipt Date: November 12, 2015 by 5:00PM local time of applicant organization
 
Small Business Innovation Research (SBIR) to Develop New Methods and Technologies for Assessment of Risk and for Early Diagnosis and Prognosis of Type 1 Diabetes (T1D) (R43/R44)
Posted Date: July 28, 2015
Open Date (Earliest Submission Date): October 18, 2015
Letter of Intent Due Date: October 18, 2015
Application Receipt Date: November 18, 2015 by 5:00PM local time of applicant organization
 
Small Business Innovation Research (SBIR) to Develop New or Improved Closed Loop Automated Technologies for Diabetes Therapy and Monitoring (R43/R44)
Posted Date: July 24, 2015
Open Date (Earliest Submission Date): October 18, 2015
Letter of Intent Due Date: October 18, 2015
Application Receipt Date: November 18, 2015 by 5:00PM local time of applicant organization
 
Career Development Programs in Diabetes Research for Pediatric Endocrinologists (K12)
Posted Date: April 21, 2015
Open Date (Earliest Submission Date): November 2, 2015
Letter of Intent Due Date: November 2, 2015
Application Receipt Date: December 3, 2015 by 5:00PM local time of applicant organization
 
Limited Competition for the Continuation of the SEARCH for Diabetes in Youth Cohort Study (UC4)
Posted Date: September 30, 2014
Open Date (Earliest Submission Date): February 10, 2015
Letter of Intent Due Date: February 10, 2015
Application Receipt Date: March 10, 2015 by 5:00PM local time of applicant organization
 
Consortium on Beta-cell Death and Survival (HIRN-CBDS) (UC4)
Posted Date: August 27, 2014
Open Date (Earliest Submission Date): February 3, 2015
Letter of Intent Due Date: February 3, 2015
Application Receipt Date: March 3, 2015 by 5:00PM local time of applicant organization
 
Type 1 Diabetes Complications IMPACT Award (DP3)
Posted Date: August 26, 2014
Open Date (Earliest Submission Date): February 19, 2015
Letter of Intent Due Date: February 19, 2015
Application Receipt Date: March 19, 2015 by 5:00PM local time of applicant organization
 
Advanced Clinical Trials to Test Artificial Pancreas Device Systems in Type 1 Diabetes (UC4)
Posted Date: June 21, 2014
Open Date (Earliest Submission Date): March 15, 2015
Letter of Intent Due Date: March 15, 2015
Application Receipt Date: April 15, 2015 by 5:00PM local time of applicant organization
 
Improving Diabetes Management in Young Children with Type 1 Diabetes (DP3)
RFA-DK-14-022
Posted Date: June 19, 2014
Open Date (Earliest Submission Date): February 18, 2015
Letter of Intent Due Date: February 18, 2015
Application Receipt Date: March 18, 2015 by 5:00PM local time of applicant organization
 

2014

Limited Competition: Data Coordinating Center for Type 1 Diabetes TrialNet (UC4)
Posted Date: August 20, 2014
Open Date (Earliest Submission Date): November 3, 2014
Letter of Intent Due Date: November 3, 2014
Application Receipt Date: December 3, 2014 by 5:00PM local time of applicant organization
 
Type 1 Diabetes TrialNet Clinical Centers (U01)
Posted Date: August 15, 2014
Open Date (Earliest Submission Date): November 3, 2014
Letter of Intent Due Date: November 3, 2014
Application Receipt Date: December 3, 2014 by 5:00PM local time of applicant organization
 
Limited Competition: Data Coordinating Center for The Environmental Determinants of Diabetes in the Young (TEDDY) Study (UC4)
Posted Date: June 25, 2014
Open Date (Earliest Submission Date): November 2, 2014
Letter of Intent Due Date: November 2, 2014
Application Receipt Date: December 2, 2014 by 5:00PM local time of applicant organization
 
Research Using Subjects From Selected Type 1 Diabetes Clinical Studies (Living Biobank) (DP3)
Posted Date: June 11, 2014
Open Date (Earliest Submission Date): October 20, 2014
Letter of Intent Due Date: October 20, 2014
Application Receipt Date: November 20, 2014 by 5:00PM local time of applicant organization

Research Using Biosamples from Selected Type 1 Diabetes Clinical Studies (DP3)
Posted Date: June 10, 2014
Open Date (Earliest Submission Date): October 20, 2014
Letter of Intent Due Date: October 20, 2014
Application Receipt Date: November 20, 2014 by 5:00PM local time of applicant organization

Diabetes Impact Award-Closed Loop Technologies: Development and Integration of Novel Components for an Automated Artificial Pancreas System (DP3)
Posted Date: May 14, 2014
Open Date (Earliest Submission Date): October 24, 2014
Letter of Intent Due Date: October 24, 2014
Application Receipt Date: November 24, 2014 by 5:00PM local time of applicant organization

Diabetes Impact Award-Closed Loop Technologies: Clinical, Physiological and Behavioral Approaches to Improve Type 1 Diabetes Outcomes (DP3)
Posted Date: May 14, 2014
Open Date (Earliest Submission Date): October 24, 2014
Letter of Intent Due Date: October 24, 2014
Application Receipt Date: November 24, 2014 by 5:00PM local time of applicant organization

Research Using Biosamples from Selected Type 1 Diabetes Clinical Studies (DP3)
Posted Date: January 7, 2013
Open Date (Earliest Submission Date): March 10, 2014
Letter of Intent Due Date: March 10, 2014
Application Receipt Date: April 10, 2014 by 5:00PM local time of applicant organization
Research Using Subjects From Selected Type 1 Diabetes Clinical Studies (Living Biobank) (DP3)
Posted Date: January 7, 2013
Open Date (Earliest Submission Date): March 10, 2014
Letter of Intent Due Date: March 10, 2014
Application Receipt Date: April 10, 2014 by 5:00PM local time of applicant organization
 
Small Business Innovation Research to Develop New Therapeutics and Monitoring Technologies for Type 1 Diabetes (T1D): Towards an Artificial Pancreas (SBIR) (R43/R44)
Posted Date: December 4, 2013
Open Date (Earliest Submission Date): February 14, 2014
Letter of Intent Due Date: February 14, 2014
Application Receipt Date: March 14, 2014 by 5:00PM local time of applicant organization
 
Biomarkers for Diabetes Complications - Non-Invasive Measures in the Eye (DP3)
Posted Date: November 6, 2013
Open Date (Earliest Submission Date): March 7, 2014
Letter of Intent Due Date: March 7, 2014
Application Receipt Date: April 7, 2014 by 5:00PM local time of applicant organization
 
Human Islet Research Network (HIRN) Coordinating Center (U01)
Posted Date: September 26, 2013
Open Date (Earliest Submission Date): January 27, 2014
Letter of Intent Due Date: January 27, 2014
Application Receipt Date: February 27, 2014 by 5:00PM local time of applicant organization
 
Human Islet Research Network Bioinformatics Center (HIRN-BC) (U01)
Posted Date: September 26, 2013
Open Date (Earliest Submission Date): January 27, 2014
Letter of Intent Due Date: January 27, 2014
Application Receipt Date: February 27, 2014 by 5:00PM local time of applicant organization
 
Consortium on Targeting and Regeneration (HIRN-CTAR) (UC4)
Posted Date: September 26, 2013
Open Date (Earliest Submission Date): January 27, 2014
Letter of Intent Due Date: January 27, 2014
Application Receipt Date: February 27, 2014 by 5:00PM local time of applicant organization
 
Consortium on Human Islet Biomimetics (HIRN-CHIB) (UC4)
Posted Date: September 26, 2013
Open Date (Earliest Submission Date): January 27, 2014
Letter of Intent Due Date: January 27, 2014
Application Receipt Date: February 27, 2014 by 5:00PM local time of applicant organization
 
Consortium on Modeling Autoimmune Interactions (HIRN-CMAI) (UC4)
Posted Date: September 26, 2013
Open Date (Earliest Submission Date): January 27, 2014
Letter of Intent Due Date: January 27, 2014
Application Receipt Date: February 27, 2014 by 5:00PM local time of applicant organization
 
Consortium on Beta-cell Death and Survival (HIRN-CBDS) (UC4)
Posted Date: September 26, 2013
Open Date (Earliest Submission Date): January 27, 2014
Letter of Intent Due Date: January 27, 2014
Application Receipt Date: February 27, 2014 by 5:00PM local time of applicant organization
 
Harvesting the Neuroimaging Cornucopia for Pancreatic Islet Imaging Reagents for Diabetes Research (DP3)
Posted Date: September 13, 2013
Open Date (Earliest Submission Date): January 20, 2014
Letter of Intent Due Date: January 20, 2014
Application Receipt Date: February 20, 2014 by 5:00PM local time of applicant organization
 
Improving Diabetes Management in Young Children with Type 1 Diabetes (DP3)
Posted Date: August 9, 2013
Open Date (Earliest Submission Date): January 19, 2014
Letter of Intent Due Date: January 19, 2014
Application Receipt Date: February 19, 2014 by 5:00PM local time of applicant organization
 
Understanding Barriers and Facilitators to Type 1 Diabetes Management in Adults (DP3)
Posted Date: August 9, 2013
Open Date (Earliest Submission Date): January 19, 2014
Letter of Intent Due Date: January 19, 2014
Application Receipt Date: February 19, 2014 by 5:00PM local time of applicant organization


2013

Type 1 Diabetes TrialNet Clinical Network Hub (U01)
Posted Date: June 18, 2013
Open Date (Earliest Submission Date): October 27, 2013
Letter of Intent Due Date: October 27, 2013
Application Receipt Date: November 27, 2013, by 5:00 PM local time of applicant organization
 
Type 1 Diabetes TrialNet Clinical Centers (U01)
Posted Date: June 18, 2013
Open Date (Earliest Submission Date): October 27, 2013
Letter of Intent Due Date: October 27, 2013
Application Receipt Date: November 27, 2013, by 5:00 PM local time of applicant organization
 
Bioengineering Interdisciplinary Training for Diabetes Research (T32)
Posted Date: December 17, 2012
Open Date (Earliest Submission Date): February 7, 2013
Letter of Intent Due Dates February 7, 2013 and October 26, 2013
Application Receipt Date: March 7, 2013 and November 26, 2013, by 5:00 PM local time of applicant organization
 
Diabetes Impact Award-Closed Loop Technologies: Clinical, Physiological and Behavioral Approaches to Improve Type 1 Diabetes Outcomes (DP3)
Posted Date: December 12, 2012
Open Date (Earliest Submission Date): February 28, 2013
Letter of Intent Due Date: February 28, 2013
Application Receipt Date: March 28, 2013 by 5:00PM local time of applicant organization
 
Diabetes Impact Award-Closed Loop Technologies: Development and Integration of Novel Components for an Automated Artificial Pancreas System (DP3)
Posted Date: December 12, 2012
Open Date (Earliest Submission Date): February 28, 2013
Letter of Intent Due Date: February 28, 2013
Application Receipt Date: March 28, 2013 by 5:00PM local time of applicant organization
 
Research Using Subjects From Selected Type 1 Diabetes Clinical Studies (Living Biobank) (DP3)
Posted Date: November 27, 2012
Open Date (Earliest Submission Date): March 2, 2013
Letter of Intent Due Date: March 2, 2013
Application Receipt Date: April 2, 2013, by 5:00 PM local time of applicant organization
 
Research Using Biosamples From Selected Type 1 Diabetes Clinical Studies (DP3)
Posted Date: October 30, 2012
Open Date (Earliest Submission Date): March 2, 2013
Letter of Intent Due Date: March 2, 2013
Application Receipt Date: April 2, 2013, by 5:00 PM local time of applicant organization
 
Small Business Innovation Research to Develop New Therapeutics and Monitoring Technologies for Type 1 Diabetes (T1D) Towards an Artifical Pancreas [SBIR (R43/R44)]
Posted Date: December 17, 2012
Open Date (Earliest Submission Date): February 6, 2013
Letter of Intent Due Date: February 6, 2013
Application Receipt Date: March 6, 2013 by 5:00PM local time of applicant organization
 
Collaborative Network for Clinical Research on Immune Tolerance (UM1)
Posted Date: November 5, 2012
Letter of Intent Due Date: February 7, 2013
Application Receipt Date: March 7, 2013

Back to Top


2012

Research Using Biosamples From Selected Type 1 Diabetes Clinical Studies (DP3)
Posted Date: September 28, 2011
Open Date (Earliest Submission Date): November 7, 2011
Letter of Intent Due Date: November 7, 2011; May 7, 2012
Application Receipt Date: December 7, 2011 and June 7, 2012 by 5:00 PM local time of applicant organization
 
Research Using Subjects From The Type 1 Diabetes TrialNet Natural History Study (Living Biobank) (DP3)
Posted Date: September 27, 2011
Open Date (Earliest Submission Date): November 7, 2011
Letter of Intent Due Date: November 7, 2011; May 7, 2012
Application Receipt Date: December 7, 2011 and June 7, 2012 by 5:00 PM local time of applicant organization
 
Bioengineering Interdisciplinary Training and Education for Type I Diabetes Research (T90/R90)
Posted Date: November 16, 2011
Open Date (Earliest Submission Date): February 14, 2012
Letter of Intent Due Date: February 14, 2012
Application Receipt Date: March 14, 2012 by 5:00 PM local time of applicant organization
 
The Human Islet Distribution Coordinating Center (UC4)
Posted Date: March 7, 2012
Open Date (Earliest Submission Date): April 16, 2012
Letter of Intent Due Date: April 16, 2012
Application Receipt Date: May 16, 2012 by 5:00 PM local time of applicant organization
 
The Collaborative Islet Transplantation Registry (UC4)
Posted Date: March 2, 2012
Open Date (Earliest Submission Date): April 16, 2012
Letter of Intent Due Date: April 16, 2012
Application Receipt Date: May 16, 2012 by 5:00 PM local time of applicant organization
 
Application Receipt Date: May 17, 2012

 

2011

Type 1 Diabetes Mouse Resource (UC4)
Posted Date: October 24, 2011
Open Date (Earliest Submission Date): February 15, 2012
Letter of Intent Due Date: February 15, 2012
Application Receipt Date: March 14, 2012, by 5:00 PM local time of applicant organization
 
Diabetes Research Training for Behavioral Scientists (T32)
Posted Date: November 1, 2011
Open Date (Earliest Submission Date): February 2, 2012
Letter of Intent Due Date: February 2, 2012
Application Receipt Date: March 2, 2012 by 5:00 PM local time of applicant organization
 
Career Development Programs in Diabetes Research for Behavioral Scientists (K12)
Posted Date: November 1, 2011
Open Date (Earliest Submission Date): February 2, 2012
Letter of Intent Due Date: February 2, 2012
Application Receipt Date: March 2, 2012 by 5:00 PM local time of applicant organization
 
Improving Adherence in Pre-teens, Adolescents and Young Adults with Type 1 Diabetes (DP3)
Posted Date: November 1, 2011
Open Date (Earliest Submission Date): February 2, 2012
Letter of Intent Due Date: February 2, 2012
Application Receipt Date: March 2, 2012 by 5:00 PM local time of applicant organization
 
Function of Type 1 Diabetes Genes (DP3)
Posted Date: October 3, 2011
Open Date (Earliest Submission Date): January 29, 2012
Letter of Intent Due Date: February 1, 2012
Application Receipt Date: February 29, 2012 by 5:00 PM local time of applicant organization
 
Small Business Innovation Research to Develop New Methods and Technologies able to Identify Individuals at Risk of Developing Type 1 Diabetes [T1D] (R43)
Posted Date: September 21, 2011
Open Date (Earliest Submission Date): November 22, 2011
Letter of Intent Due Date: November 22, 2011
Application Receipt Date: December 22, 2011 by 5:00 PM local time of applicant organization
 
Nonhuman Primate Islet/Kidney Transplantation Tolerance (U01)
Posted Date: August 17, 2011
Open Date (Earliest Submission Date): November 14, 2011
Letter of Intent Due Date: November 14, 2011
Application Receipt Date: December 14, 2011 by 5:00 PM local time of applicant organization
 
Nonhuman Primate Islet/Kidney Transplantation Tolerance (U19)
Posted Date: August 17, 2011
Letter of Intent Due Date: November 14, 2011
Application Receipt Date: December 14, 2011 by 5:00 PM local time of applicant organization
 
Small Business Innovation Research to Develop New Therapeutics and Monitoring Technologies for Type 1 Diabetes (T1D) Towards an Artificial Pancreas [(SBIR) (R43/R44)]
Posted Date: September 20, 2011
Open Date (Earliest Submission Date): October 23, 2011
Letter of Intent Due Date: October 26, 2011
Application Receipt Date: November 23, 2011 by 5:00 PM local time of applicant organization
 
Standardization of C-Peptide and HbA1C (UC4)
Posted Date: August 9, 2011
Open Date (Earliest Submission Date): October 20, 2011
Letter of Intent Due Date: October 20, 2011
Application Receipt Date: November 17, 2011 by 5:00 PM local time of applicant organization
 
Cooperative Study Group for Autoimmune Disease Prevention (U01)
Posted Date: June 17, 2011
Open Date (Earliest Submission Date): September 7, 2011
Letter of Intent Due Date: October 7, 2011
Application Receipt Date: November 8, 2011 by 5:00 PM local time of applicant organization
 
Clinical Trial Planning Grants in Type 1 Diabetes (R34)
Posted Date: May 2, 2011
Open Date (Earliest Submission Date): February 15, 2012
Letter of Intent Due Date: February 16, 2012
Application Receipt Date: March 15, 2012 by 5:00 PM local time of applicant organization
 
Career Development Programs in Diabetes Research for Pediatric Endocrinologists (K12)
Posted Date: February 28, 2011
Open Date (Earliest Submission Date): March 28, 2011
Letter of Intent Due Date: March 28, 2011
Application Receipt Date: April 28, 2011, by 5:00 PM local time of applicant organization
 
Feasibility Studies for Clinical Trials in Type 1 Diabetes (R03)
Posted Date: February 4, 2011
Open Date (Earliest Submission Date): March 4, 2011
Letter of Intent Due Date: March 8, 2011
Application Receipt Date: April 4, 2011, by 5:00 PM local time of applicant organization
 
Type 1 Diabetes Impact Award (DP3)
Posted Date: September 16, 2010
Open Date (Earliest Submission Date): February 11, 2011
Letter of Intent Due Date: February 11, 2011
Application Receipt Date: March 11, 2011, by 5:00 PM local time of applicant organization

 

2010

Small Business Innovation Research to Develop New Therapeutics and Monitoring Technologies for Type 1 Diabetes (T1D). Towards an Artificial Pancreas [(SBIR) (R43/R44)]
Posted Date: May 19, 2010
Open Date (Earliest Submission Date): October 29, 2010
Letter of Intent Due Date: November 1, 2010
Application Receipt Date: November 29, 2010
 
Animal Models of Diabetic Complications Consortium (AMDCC) Pilot and Feasibility Opportunities
Application Receipt Date: May 3, 2010
Back to Top
 

2009

Innovative Patient Outreach Programs and Ocular Screening Technologies to Improve Detection of Diabetic Retinopathy (SBIR [R43/R44])
Posted Date: December 9, 2008
Open Date (Earliest Submission Date): February 23, 2009
Application Receipt Date: March 23, 2009; December 23, 2009
 
Beta Cell Biology Consortium (U01)
Posted Date: August 14, 2009
Letter of Intent Due Date: October 26, 2009
Application Receipt Date: November 23, 2009
 
Small Business Innovation Research to Develop New Therapeutics and Monitoring Technologies for Type 1 Diabetes (T1D). Towards an Artificial Pancreas (SBIR) [R43/R44])
Posted Date: December 10, 2008
Open Date (Earliest Submission Date): March 15, 2009
Letter of Intent Due Date: March 16, 2009
Application Receipt Date: April 15, 2009
 
Fine Mapping and Function of Genes for Type 1 Diabetes (DP3)
Posted Date: October 16, 2008
Open Date (Earliest Submission Date): February 27, 2009
Letter of Intent Due Date: February 27, 2009
Application Receipt Date: March 30, 2009
 
Limited Competition: Continuation of the Clinical Islet Transplantation (CIT) Consortium (U01)
Posted Date: January 13, 2009
Application Receipt Date: March 19, 2009
 
Closed Loop Technologies: Clinical and Behavioral Approaches to Improve Type 1 Diabetes Outcomes (R01)
Posted Date: November 28, 2008
Open Date (Earliest Submission Date): February 19, 2009
Letter of Intent Due Date: February 19, 2009
Application Receipt Date: March 19, 2009
 
Closed Loop Technologies: Pilot and Exploratory Clinical and Behavioral Approaches to Improve Type 1 Diabetes Outcomes (R21)
Posted Date: November 28, 2008
Open Date (Earliest Submission Date): February 19, 2009
Letter of Intent Due Date: February 19, 2009
Application Receipt Date: March 19, 2009

Type 1 Diabetes TrialNet: Clinical Centers (U01)
Posted Date: December 24, 2008
Letter of Intent Due Date: February 10, 2009
Application Receipt Date: March 10, 2009

Seeding Collaborative Research in Beta Cell Biology (SCRBCB) Program
This program will provide research support for a limited time (18 months) to enable eligible investigative teams to explore the feasibility of concepts related to the mission of the Beta Cell Biology Consortium. Specific details can be found on the BCBC website at www.betacell.org/seeding/. Research areas open to support through the SCRBCB program are:
  • Generation of humanized mouse models for the assessment and enhancement of human islet regenerative capacity.
  • Production and use of T1D-specific induced pluripotent stem cells (iPSCs).
  • Transdifferentiation or reprogramming of a differentiated cell type into a pancreatic beta-cell.
  • Generation of engineered pancreatic islet-like structures for engraftment.
  • Non-invasive technology for imaging of beta-cell mass in vivo.

 

Request for Proposals: Islet Cell Distribution Coordinating Center
Application Receipt Date: 3:00 EST on February 11, 2009


2008

Beta Cell Biology Consortium 2008 Pilot and Feasibility Program
This Pilot and Feasibility Program will provide research support for a limited time (1-2 years) to enable eligible investigators to explore the feasibility of concepts related to the mission of the Beta Cell Biology Consortium (BCBC). Areas of research particularly relevant to the current effort of the consortium include, but are not limited to:
  • production of human beta-cells for cell replacement strategies
  • beta-cell regeneration and regulation of beta-cell mass
  • small molecules or secreted factors controlling beta-cell fate or beta-cell regeneration, or
  • non-invasive imaging of beta-cell mass in vivo
Type 1 Diabetes Pathfinder Award (DP2)
Posted Date: November 26, 2007
Open Date (Earlierst Submission Date): March 10, 2008
Letter of Intent Due Date: March 13, 2008
Application Receipt Date: April 10, 2008 

Back to Top

 

2007

Limited Competition: The Environmental Determinants of Diabetes in the Youth (TEDDY) study (U01)
Posted Date: June 21, 2007
Letter of Intent Due Date: July 27, 2007
Application Receipt Date: August 29, 2007
Back to Top



2006

High-Density Genotyping of Diabetes and Diabetic Complications Sample Collections (R01)
Posted Date: December 28, 2005
Letter of Intent Due Date: March 14, 2006
Application Receipt Date: April 12, 2006
 
Biomarker Development for Diabetic Complications (R21)
Posted Date: April 19, 2006
Letter of Intent Due Date: November 13, 2006
Application Receipt Date: December 12, 2006
 
Cooperative Multicenter Diabetes Research Network for Hypoglycemia Prevention (U10)
Posted Date: October 10, 2006
Letter of Intent Due Date: October 23, 2006
Application Receipt Date: November 22, 2006
 
Non-Human Primate Islet/Kidney Transplantation Tolerance (U01, U19)
Posted Date: May 10, 2006
Letter of Intent Due Date: August 22, 2006
Application Receipt Date: September 22, 2006
 
Biomarkers of Autoimmunity in Type 1 Diabetes (R21)
Posted Date: December 28, 2005
Letter of Intent Due Date: March 14, 2006
Application Receipt Date: April 12, 2006
 
Toward Imaging the Pancreatic Beta Cell in People (R01)
Posted Date: December 13, 2005
Letter of Intent Due Date: March 14, 2006
Application Receipt Date: April 12, 2006
Back to Top



2005

Small Business Innovation Research to Develop New Therapeutics and Monitoring Technologies for Type 1 Diabetes (T1D) and its Complications (SBIR [R43/R44]) 
Posted Date: October 18, 2005
Letter of Intent Due Date: February 15, 2006
Application Receipt Date: March 15, 2006
 
Small Business Technology Transfer to Develop New Therapeutics and Monitoring Technologies for Type 1 Diabetes (T1D) and its Complications (STTR [R41/R42])
Posted Date: October 18, 2005
Letter of Intent Due Date: February 15, 2006
Application Receipt Date: March 15, 2006
 
Human Pancreatic Islet Cell Resources (ICRs)
Posted Date: July 18, 2005
Letter of Intent Due Date: December 6, 2005
Application Receipt Date: January 6, 2006
 
Animal Models of Diabetic Complications Consortium
Posted Date: August 17, 2005
Letter of Intent Due Date: October 21, 2005
Application Receipt Date: November 18, 2005
 
Mouse Metabolic Phenotyping Centers Consortium
Posted Date: June 8, 2005
Letter of Intent Due Date: October 14, 2005
Application Receipt Date: November 16, 2005
 
Administrative Supplements for a Drug Screening Program for Diabetic Complications
Posted Date: August 17, 2005
Request Receipt Date: December 1, 2005
 
Cooperative Study Group for Autoimmune Disease Prevention
Posted Date: May 12, 2005
Letter of Intent Due Date: September 12, 2005
Application Receipt Date: October 12, 2005
 
Incidence, Natural History, and Quality of Life of Diabetes in Youth
Posted Date: May 11, 2005
Letter of Intent Due Date: May 25, 2005
Application Receipt Date: June 24, 2005
 
Beta Cell Regeneration for Diabetes Therapy
Posted Date: March 1, 2005
Letter of Intent Due Date: May 22, 2005
Application Receipt Date: June 22, 2005
 
Preclinical Study of Efficacy in Animal Models of Diabetic Complications
NIH-NIDDK-O5-04
 
Preclinical Study of Efficacy in Animal Models of Type 1 Diabetes
NIH-NIDDK-O5-05
Collaborative Studies on Angiogenesis and Diabetic Complications
Posted Date: November 3, 2004
Letter of Intent Due Date: February 17, 2005
Application Receipt Date: March 17, 2005
 
Immunobiology of Xenotransplantation
Posted Date: August 6, 2004
Letter of Intent Due Date: October 22, 2004
Application Receipt Date: November 22, 2004
 
Beta Cell Biology Consortium (U19)
Posted Date: June 21, 2004
Letter of Intent Due Date: October 19, 2004
Application Receipt Date: November 19, 2004
 
Beta Cell Biology Consortium (U01)
Posted Date: June 21, 2004
Letter of Intent Due Date: October 19, 2004
Application Receipt Date: November 19, 2004
 
Cooperative Clinical Islet Transplantation Consortia: Data Coordinating Center
Posted Date: December 5, 2003
Letter of Intent Due Date: March 16, 2004
Application Receipt Date: April 13, 2004
 
Cooperative Clinical Islet Transplantation Consortia: Clinical Centers
Posted Date: December 5, 2003
Letter of Intent Due Date: March 16, 2004
Application Receipt Date: April 13, 2004
 
Progression of Cardiovascular Disease in Type 1 Diabetes
Posted Date: December 4, 2003
Letter of Intent Due Date: February 24, 2004
Application Receipt Date: March 24, 2004



2003

Bench to Bedside Research on Type 1 Diabetes and Its Complications
Posted Date: August 14, 2003
Letter of Intent Due Date: January 20, 2004
Application Receipt Date: February 20, 2004
 
Bench to Bedside Research on Type 1 Diabetes and its Complications
Posted Date: August 30, 2002
Letter of Intent Due Date: January 29, 2003
Application Receipt Date: February 26, 2003
 
Hypoglycemia in Patients with Type 1 Diabetes
Posted Date: August 14, 2003
Letter of Intent Due Date: January 20, 2004
Application Receipt Date: February 20, 2004
 
Innovative Partnerships in Type 1 Diabetes Research
Posted Date: June 26, 2003
Letter of Intent Due Date: October 16, 2003
Application Receipt Date: November 13, 2003
 
Pilot and Feasibility Program in Human Islet Biology
Posted Date: July 14, 2003
Letter of Intent Due Date: October 20, 2003 and June 20, 2004
Application Receipt Date: November 20, 2003 and July 20, 2004
 
Proteomics and Metabolomics in Type 1 Diabetes and Its Complications
Posted Date: October 24, 2003
Letter of Intent Due Date: February 18, 2004
Application Receipt Date: March 18, 2004
 
Seeding Collaborative Research in Beta Cell Biology (SCRBCB)
Posted Date: May 29, 2003
Application Receipt Date: October 1, 2003
 
Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) RFA in Type 1 Diabetes and Its Complications
Posted Date: August 28, 2003
Letter of Intent Due Date: January 19, 2004
Application Receipt Date: February 19, 2004
Back to Top



2002

Bench to Bedside Research on Type 1 Diabetes and its Complications
Posted Date: October 11, 2001
Letter of Intent Due Date: February 14, 2002
Application Receipt Date: March 14, 2002
 
Comprehensive Programs in Beta Cell Biology
Posted Date: August 14, 2001
Letter of Intent Due Date: February 13, 2002
Application Receipt Date: March 13, 2002
 
Bioinformatics Integration Support Contract
RFP-NIH-NIAID-DAIT-02-16
Posted Date: November 27, 2001
Application Receipt Date: February 15, 2002
 
Consortium for Identification of Environmental Triggers of Type 1 Diabetes
Posted Date: January 22, 2002
Letter of Intent Due Date: March 5, 2002
Application Receipt Date: April 15, 2002
 
Data and Biosample Repository
 
Effects of Hypoglycemia on Neuronal and Glial Cell Function
Posted Date: August 7, 2001
Letter of Intent Due Date: February 15, 2002
Application Receipt Date: March 15, 2002
 
Feasibility Projects to test Strategies for Preventing or Slowing the Progression of Diabetic Nephropathy
Posted Date: September 17, 2001
Letter of Intent Due Date: January 17, 2002
Application Receipt Date: February 14, 2002
 
Gene Transfer Approaches to Enhance Islet Transplantation
Posted Date: September 20, 2001
Letter of Intent Due Date: November 15, 2001
Application Receipt Date: December 12, 2001
 
Imaging Early Markers of Diabetic Microvascular Complications in Peripheral Tissue
Posted Date: November 26, 2001
Letter of Intent Due Date: February 15, 2002
Application Receipt Date: March 15, 2002
 
Imaging Pancreatic Beta Cell Mass, Function, Engraftment or Inflammation
Posted Date: August 1, 2001
Letter of Intent Due Date: February 15, 2002
Application Receipt Date: March 15, 2002
 
Innovative Partnerships in Type 1 Diabetes Research
Posted Date: October 2, 2001
Letter of Intent Due Date: February 14, 2002
Application Receipt Date: March 14, 2002
 
Sensor Development and Validation
Posted Date: February 25, 2002
Letter of Intent Due Date: March 29, 2002
Application Receipt Date: April 24, 2002
 
Surrogate Endpoints for Diabetic Microvascular Complications
Posted Date: August 30, 2001
Letter of Intent Due Date: January 17, 2002
Application Receipt Date: February 14, 2002
 
Training Programs in Diabetes Research for Pediatric Endocrinologists
Posted Date: October 18, 2001
Letter of Intent Due Date: February 26, 2002
Application Receipt Date: March 26, 2002
Back to Top



2001

Beta Cell Biology Consortium
Posted Date: October 11, 2000
Letter of Intent Due Date: March 16, 2001
Application Receipt Date: April 17, 2001
 
Cooperative Multicenter Research Network to Test Glucose Sensors in Children With Type 1 Diabetes Mellitus
Posted Date: February 22, 2001
Letter of Intent Due Date: March 27, 2001
Application Receipt Date: May 11, 2001
 
Diabetic Macular Edema Clinical Trials Network
Posted Date: June 7, 2001
Application Receipt Date: October 26, 2001
 
Gene Therapy Approaches for Diabetes and Its Complications
Posted Date: August 30, 2000
Letter of Intent Due Date: October 16, 2000
Application Receipt Date: November 16, 2000
 
Human Pancreatic Islet Cell Resources (ICRs)
Posted Date: January 3, 2001
Letter of Intent Due Date: February 8, 2001
Application Receipt Date: March 21, 2001
 
Mouse Models of Diabetic Complications Consortium
Posted Date: October 31, 2000
Letter of Intent Due Date: February 28, 2001
Application Receipt Date: March 28, 2001
 
Non-Mouse Models of Diabetes Complications in Cardiovascular and Microvascular Diseases
Posted Date: November 20, 2000
Letter of Intent Due Date: February 26, 2001
Application Receipt Date: March 21, 2001
 
Non-Human Primate Immune Tolerance Cooperative Study Group
Posted Date: January 25, 2001
Letter of Intent Due Date: June 11, 2001
Application Receipt Date: July 17, 2001
 
Oral Microbiology/Immunology of Type 1 Diabetes
Posted Date: January 30, 2001
Letter of Intent Due Date: March 12, 2001
Application Receipt Date: April 12, 2001
 
Type 1 Diabetes Trialnet: Core Support Facilities
Posted Date: October 5, 2000
Letter of Intent Due Date: February 28, 2001
Application Receipt Date: March 29, 2001
 
Understanding Hypoglycemia Unawareness in Patients with Diabetes
Posted Date: July 27, 2001
Letter of Intent Due Date: October 14, 2001
Application Receipt Date: November 21, 2001
Back to Top



2000

Cooperative Study Group for Autoimmune Disease Prevention
Posted Date: September 7, 2000
Letter of Intent Due Date: December 15, 2000
Application Receipt Date: February 26, 2001
 
Innovative Grants on Immune Tolerance
Posted Date: February 9, 2000
Letter of Intent Due Date: August 1, 2000
Application Receipt Date: September 14, 2000
 
New Strategies for the Treatment of Type 1 Diabetes
Posted Date: September 30, 1999
Letter of Intent Due Date: March 14, 2000
Application Receipt Date: April 14, 2000
 
Neurobiology of Diabetic Complications
Posted Date: January 13, 2000
Letter of Intent Due Date: March 24, 2000
Application Receipt Date: April 25, 2000
Back to Top



1999

Collaborative Network for Clinical Research on Immune Tolerance
Posted Date: January 15, 1999
Application Receipt Date: May 14, 1999
 
Functional Genomics of the Developing Endocrine Pancreas
Posted Date: December 4, 1998
Letter of Intent Due Date: February 10, 1999
Application Receipt Date: March 10, 1999
 
Neurological Complications of Diabetes
Posted Date: December 22, 1998
Letter of Intent Due Date: March 16, 1999
Application Receipt Date: April 27, 1999
 
Pilot Studies for New Therapies for Type 1 Diabetes and its Complications
Posted Date: January 8, 1999
Letter of Intent Due Date: March 1, 1999
Application Receipt Date: March 30, 1999
Back to Top



1998

Cellular and Molecular Approaches to Achieving Euglycemia
Posted Date: November 21, 1997
Letter of Intent Due Date: February 19, 1998
Application Receipt Date: March 19, 1998
 
Glucose Sensors in the Treatment of Diabetes
Posted Date: November 21, 1997
Letter of Intent Due Date: February 19, 1998
Application Receipt Date: March 19, 1998
 
Immunopathogenesis of Type 1 Diabetes
Posted Date: November 21, 1997
Letter of Intent Due Date: February 19, 1998
Application Receipt Date: March 19, 1998
 
Pathogenesis and Therapy of Complications of Diabetes
Posted Date: November 21, 1997
Letter of Intent Due Date: February 19, 1998
Application Receipt Date: March 19, 1998